含羞草社区

?
?
?
Home Tags Posts tagged with "Geng Ke"

Tag: Geng Ke

Metis IPO is world’s first AI driven nano-delivery firm listing

Metis TechBio debuts on the HKEX on 13 May, raising HKD2.1 billion in the world’s first listing of an AI driven nano-delivery platform company

Firms act on medtech maker Cofoe Medical’s HKD1.06bn IPO

Cofoe Medical Technology lists on the HKEX main board becoming the first home medical equipment maker to achieve a dual listing

Firms assist Eastroc Beverage on HKD10.1bn HKEX IPO

Health drinks producer Eastroc Beverage has debuted on the HKEX, raising HKD10.1 billion. HSF Kramer, DeHeng , Jia Yuan and O’Melveny advised on the listing

The A-List 2024-25: Visionaries

The A-List 2024-25: Legal leaders and influential lawyers in China's legal market

Four law firms counsel on HKD905m Laopu Gold Hong Kong IPO

O’Melveny, Global Law Office, Linklaters and Haiwen & Partners have clinched roles in Chinese jewellery brand Laopu Gold’s listing on the HKEX

The A-List 2023-24: Visionaries

The A-List 2023-24: Legal leaders and influential lawyers in China's legal market

Cancer drug firm Adlai Nortye raises USD97.5m in Nasdaq IPO

O’Melveny, Han Kun Law Offices, Maples Group, Latham & Watkins and Zhong Lun Law Firm advised on cancer drug developer Adlai Nortye’s Nasdaq debut

Fourth Paradigm clinches HKD1.02bn IPO on fourth endeavour

China’s AI unicorn Fourth Paradigm, after three previous attempts, has successfully listed on the HKEX raising HKD1.02 billion (USD130 million)

Luzhu Biotechnology launches HKD341m IPO via chapter 18A

Luzhu Biotechnology debuted on the HKEX through chapter 18A, the first biotech company without any revenue or profits to be listed this year, raising USD43.45 million

O’Melveny acts on Acotec Scientific’s partial offering

O’Melveny advised China’s medical technology company, Acotec Scientific Holdings, on the voluntary partial offer for a majority stake of up to 65% by US-listed Boston Scientific Group

The A-List 2022

After thorough editorial survey and research, China Business Law Journal presents the elite lawyers in China’s legal market

Correspondents

Board Observer Regulationvideo

RBI scrutiny tightens over NBFC ‘board observers’

By Swathi Girimaji and Theertha Aiyappa, Bharucha & Partners
Foreign Decree Enforcement Indiavideo

Paper reciprocity undermines foreign decrees

By Ambar Bhushan and Aaryan Goyal, Bharucha & Partners
Biosimilar Patent Litigation India

Trends in biologic patent litigation

By Swati Sharma and Gitika Suri, Cyril Amarchand Mangaldas
konektadong-pinoy-act-expanding-access-redefining-competition

Konektadong Pinoy Act: Expanding access, redefining competition

By Jayson P Baltazar, ACCRALAW

Follow us on LinkedIn